“Efficacy and Safety of Ruxolitinib Cream by Anatomic Region in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3”. 2024. SKIN The Journal of Cutaneous Medicine 8 (6): s453. https://doi.org/10.25251/skin.8.supp.453.